Pyramidal cell types and 5-HT2A receptors are essential for psilocybin's lasting drug action
Ling-Xiao Shao, Clara Liao, Pasha A. Davoudian, Neil K. Savalia, Quan Jiang, Cassandra Wojtasiewicz, Diran Tan, Jack D. Nothnagel, Rongjian Liu, Samuel C. Woodburn, Olesia M. Bilash, Hail Kim, Alicia Che, Alex C. Kwan
This study identifies specific pyramidal cell types and 5-HT2A receptors in the medial frontal cortex as essential for psilocybin's long-term therapeutic effects.
bioRxiv · Nov 2, 2024 · PreprintNeuroscience